Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use. 
 
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem. 

 

She describes:

  • How consent is or has been documented
  • The benefits of electronic consent documentation
  • Specific consent attributes, e.g. genetic testing
  • Handling consent requirements from different countries or institutions
  • Understanding consent for future use, including limitations and expirations

Learn more at https://www.q2labsolutions.com/labmatrix

Share | Download(Loading)
Podbean App

Play this podcast on Podbean App